Daphne Karydas has been appointed senior vice president of Global Investor Relations and Strategy, Allergan. Ms. Karydas will lead the company’s engagement with the investment community, and will work with the Executive Leadership Team to develop and execute the company’s long-term business strategy. Ms. Karydas will report to Tessa Hilado, chief financial officer of Allergan.

“I am delighted to name Daphne to this new role and excited to work with her to continue to enhance our relationships with the investment community, while simultaneously focusing on our long-term growth strategy,” said Ms. Hilado. “Daphne’s outstanding reputation and strong relationships across the financial community coupled with her deep healthcare and industry knowledge provides an excellent fit for this newly created role. She will be a vital leader for our organization as Allergan continues to deliver short- and long-term growth for our shareholders.”

Ms. Karydas has more than 16 years of industry experience as an institutional investor and financial analyst in the biopharmaceutical sector, most recently at J.P. Morgan Asset Management. Previously, she was a healthcare Equity Research Analyst and Portfolio Manager at The Boston Company Asset Management, a Bank of New York Mellon company. Ms. Karydas also served as vice president at Goldman Sachs where she worked in the Investment Banking Division and Asset Management focused on healthcare companies.